İltihabi Barsak Hastalığı (İBH)
Özet
İltihabi barsak hastalıkları (İBH), temel olarak ülseratif kolit (ÜK) ve Crohn hastalığını (CH) kapsayan, etyolojisi tam bilinmeyen kronik süreçli rahatsızlıklardır. Ülseratif kolit, genellikle rektumdan başlayarak kolona yayılan, mukoza ve submukozayı etkileyen diffüz bir iltihaplanma ile karakterizeyken; Crohn hastalığı sindirim sisteminin herhangi bir segmentinde görülebilen, tüm barsak duvarını tutan (transmural) ve yamasal (skip) lezyonlarla seyreden bir yapıdadır. Her iki hastalığın tanısında klinik, laboratuvar, endoskopik ve radyolojik bulguların yanı sıra biyopsi örneklerinin patolojik incelemesi kritik rol oynar. Patolojik olarak ÜK'te kript distorsiyonu, bazal plazmositoz ve kript abseleri ön plandayken; CH'da non-nekrotizan epiteloid granulomlar, fissürleşen ülserler ve transmural lenfoid agregatlar tipiktir. Bu hastalıklar, özellikle sekiz yılı aşan vakalarda artmış displazi ve kolorektal kanser riski taşıdığından düzenli kolonoskopik takip gerektirir. Bazı durumlarda morfolojik bulgular örtüştüğünde kesin ayrım yapılamaz ve bu tablo "indetermine kolit" olarak adlandırılır. Tedavi süreçleri farklılık gösterdiğinden, doğru ayırıcı tanı hastanın yaşam kalitesi ve komplikasyon yönetimi açısından hayati önem taşır.
Inflammatory bowel diseases (IBD) are chronic inflammatory conditions primarily comprising ulcerative colitis (UC) and Crohn's disease (CD), with an etiology that remains not fully understood. While ulcerative colitis is characterized by diffuse mucosal inflammation typically starting from the rectum and extending proximally into the colon, Crohn's disease is a transmural granulomatous process that can involve any segment of the gastrointestinal tract with characteristic skip lesions. The diagnosis of both conditions relies on a combined evaluation of clinical, laboratory, endoscopic, and radiological findings, supplemented by the pathological examination of biopsy specimens. Pathologically, UC is dominated by crypt distortion, basal plasmacytosis, and crypt abscesses, whereas CD is characterized by non-necrotizing epithelioid granulomas, fissuring ulcers, and transmural lymphoid aggregates. These diseases carry an increased risk of dysplasia and colorectal cancer, particularly in cases exceeding eight years, necessitating regular colonoscopic surveillance. In instances where morphological features overlap and a definitive distinction cannot be made, the condition is termed "indeterminate colitis". Since treatment protocols differ, an accurate differential diagnosis is vital for enhancing the patient's quality of life and managing potential complications effectively.
Referanslar
Odze R. Diagnostic problems and advances in inflammatory bowel disease. Mod Pathol 2003:16(4);347-358.
Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterol 2004;126:1504-1517.
Bridger S, Lee JC, Bjarnason I, et al. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn’s disease and non-smokers develop ulcerative colitis. Gut 2002;51:21-25.
Orholm M, Binder V, Sorensen TI, et al. Concordance of inflammatory bowel disease among Danish twins: results of nationwide study. Scand J Gastroenterol 2000;35:1075-1081.
Thompson NP, Driscoll R, Pounder RE, et al. Genetic versus environment in inflammatory bowel disease: results of British twin study. Br Med J 1996;312:95-96.
Parkes M, Barmada MM, Satsangi J, et al. The IBD locus shows linkage heterogeneity between ulcerative colitis and Crohn disease. Am J Human Genet 2000;67:1605-1610.
Patil DT, Greenson JK, Odze RD. (2015). Inflammatory disorders of the large intestine. In Odze RD, Goldblum JR (Eds). Odze and Goldblum’s surgical pathology of the GI tract, liver, biliary tract and pancreas (3rd ed., pp. 436-511). Elsevier Saunders Philadelphia.
Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol 2006;101(10):2410-2422.
Carucci LR, Levine MS. Radiographic imaging of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31(1):93-117.
Elmas N. İnflamatuar barsak hastalıklarında radyolojik bulgular. Turkiye Klinikleri J Gastroenterohepatol-Special Topics. 2012;5(3):58-62.
Göral V. Ülseratif kolitte endoskopik bulgular. Turkiye Klinikleri J Gastroenterohepatol-Special Topics. 2009;2(1):34-40.
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(suppl A):5-36.
Mutinga ML, Odze RD, Wang HH, et al. The clinical significance of right-sided colonic inflammation in patient with left-sided chronic ulcerative colitis. İnflamm Bowel Dis 2004;10:215-219.
İlter T, Oruç N. Filiform polyposis of ulcerative colitis. Endoscopy 2010;18(2):44-45.
DeRoche TC, Xiao S-Y, Liu X. Histological evaluation in ulcerative colitis. Gastroenterol Report 2014;178-192.
Pai RK, Jairath V, Casteele NV, et al. The emerging role histologic disease activity assessment in ulcerative colitis. Gastrointest Endoscopy 2018;88(6):887-898.
Arkteg CB, Sorbye SW, Riis LB, et al. Real-life evaluation of histologic scores for ulcerative colitis in remission. Plos One 2021;16(3):e0248224.
Bogomoletz WV, Flejou JF. Newly recognized forms of colitis: collagenous colitis, microscopic (lymphocytic) colitis, and lymphoid folicular proctitis. Semin Diagn Pathol 1991;8:178-189.
Odze R, Antonioli D, Peppercorn M, et al. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosa biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol 1993;17:869-875.
Patil DT, Odze RD. Biopsy diagnosis of colitis: an algorithmic approach. Virchow Archiv 2017;472(1):67-80.
Joo M, Odze RD. Rectal sparing and skip lesions in ulcerative colitis: a comparative study of endoscopic and histologic findings in patients who underwent proctocolectomy. Am J Surg Pathol 2010;34(5):689-696.
Andersson RE, Olaison G, Tysk C, et al. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001;344:808-814.
Washington K, Greenson JK, Montgomery E, et al. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol 2002;26:1441-1449.
Haskell H, Andrews CW, Reddy SI, et al. Pathological features and clinical significance of ‘’backwash ileitis’’ in ulcerative colitis. Am J Surg Pathol 2005;29:1472-1481.
Heuschen UA, Hinz U, Allemeyer EH, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterol 2001;120:841-847.
Honma J, Mitomi H, Murakami K, et al. Nodular duodenitis involving CD8+ cell infiltration in patients with ulcerative colitis. Hepatogastroenterology 2001;48:1604-1610.
Lin J, McKenna BJ, Appelman HD. Morphologic findings in upper gastrointestinal biopsies of patients with ulcerative colitis: a controlled study. Am J Surg Pathol 2010;34:1672-1677.
Yantiss RK, Sapp HL, Farraye FA, et al. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol 2004;28:999-1006.
Geboes K. What Histologic features best differentiate Crohn’s Disease from Ulcerative Colitis? Inflamm Bowel Dis 2008;14(S2):S168-S169.
Schofield JB, Haboubi N. Histopathological mimics of inflammatory bowel disease. İnflamm Bowel Dis 2019;20(20):1-15.
DiLauro S, Crum-Cianflone NF. Ileitis: When it is not Crohn's Disease. Curr Gastroenterol Rep 2010;12(4): 249–258.
Bhaijee F, Arnold C, Lam-Himlin D, et al. Infectious mimics of inflammatory bowel disease. Diagn Histopathol 2015;21(/):267-275.
Risques RA, Lai LA, Himmetoğlu C, et al. Ulcerative colitis associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res 2011;71(5):1669-1679.
Dağlı Ü. Ülseratif kolitte displazi tespitinde ve tedavisinde gelişmeler. Güncel Gastroenteroloji 2018;22(3):141-147.
Üstündağ Y. Ülseratif kolitte tarama (Kolonoskopik Sürveyans) ve prognoz. Turkiye Klinikleri J Gastroenterohepatol-Special Topics 2009;2(1):67-72.
Tytgat GNJ, Dhir V, Gopinath N. Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease. Eur J Cancer 1995;31(7):1174-1177.
Vieth M, Behrens H, Stolte M. Sporadik adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 2006;55:1151-1155.
Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992;33:938-941.
Terzi C, Canda AE. Ülseratif kolit ve cerrahi tedavi. SSK Tepecik Hast Derg 2004;14(3):141-151.
Feuerstein JD, Cheifetz AS. Crohn disease epidemiology, diagnosis and management. Mayo Clin Proc 2017;92(7):1088-1103.
Laas MW, Roggenbuck D, Conrad K. Diagnosis and classification of Crohn’s disease. Autoimmun Rev 2014;13(4-5):467-471.
Freeman JH. Natural history and long-term clinical course of Crohn’s disease. World J Gastrointerol 2014;20(1):31-36.
Castro M, Papadatou B, Baldassare M, et al. Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003). Inflamm Bowel Dis 2008;14:1246-1252.
Teahon K, Smethurst P, Pearson M, et al. The effect of elemental diet on intestinal permeability and inflammation in Crohn’s disease. Gastroenterol 1991;101:84-89.
Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterol 1998;115:182-205.
Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterol 2011;140:1704-1712.
Permpoon V, Pongpirul K, Anuras S. Five-year clinical outcomes of Crohn’s disease: a report of 287 multiethnic cases from an International Hospital in Thailand. Clin Experim Gastroenterol 2019;12:203-208.
Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 1996;379:821-823.
Ohmen JD, Yang HY, Yamamoto KK, et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn’s disease, but not in ulcerative colitis. Hum Mol Genet 1996;5:1679-1683.
Ha F, Khalil H. Crohn’s disease: a clinical update. Ther Adv Gastroenterol 2015;8(6):352–359.
Karlsen TH, Hampe J, Wiencke K, et al. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol 2007;102:115-121.
Roggenbuck D, Hausdorf G, Martinez-Gamboa L, et al. Identification of GP2, the major zymogen granule membrane glycoprotein, as theautoantigen of pancreatic antibodies in Crohn's disease. Gut 2009;58:1620-1628.
Baumgart CD, Sandborn WJ. Crohn’s disease. Lancet 2012;380:1590-1605.
Bodily KD, Fletcher JG, Solem CA, et al. Crohn diasease: mural attenuation and thickness at contrast-enhanced CT enterography-correlation with endoscopic and histologic findings of inflammation. Radiology 2006;238:505-516.
Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assesment of ileal Crohn’s disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006;55:1561-1567.
Hudesman D, Mazurek J, Swaminath A. Capsule endoscopy in Crohn’s disaese: Are we seeing any better? World J Gastroenterol 2014;20(36):13044-13051.
Khanna R, Bouguen G, Feagan BG, et al. A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn’s disease: recommendations for clinical trial design. Inflamm Bowel Dis 2014;20(10):1850-1861.
Berg DF, Bahadursingh AM, Kaminiski DL, et al. Acute surgical emergencies in inflammatory bowel disease. Am J Surg 2002;184:45-51.
Denoya P, Canedo J, Berho M, et al. Granulomas in Crohn’s disease: does progression through the bowel layers affect presentation or predict recurrence? Colorectal Dis 2011;13:1142-1147.
Mojtahed A, Khanna R, Sandborn WJ, et al. Assesment of histological disease activity in Crohn’s disease: A systematic review. Inflamm Bowel Dis 2014;20(11):2092-2103.
Harpaz N, Friedman S, George J. Superficial Crohn’s colitis: pathological and clinical features including long-term follow up. Mod Pathol 2001;14:86A.
Soucy G, Wang HH, Farraye FA, et al. Clinical and pathological analysis of colonic Crohn’s disease, including a subgroup with ulcerative colitis-like features. Mod Pathol 2012;25:295-307.
Yantiss RK, Odze RD. Diagnostic difficulties in inflammatory bowel disease pathology. Histopathology 2006;48:116-132.
Yantiss RK, Odze RD. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease. Am J Gastroenterol 2007;102:1-15.
Ye Z, Lin Y, Cao Q, et al. Granulomas as the most useful histopathological feature in distinguishing between Crohn’s disease and intestinal tuberculosis in endoscopic biopsy specimens. Medicine 2015;94(49):1-9.
Langholz E. Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol 2010;3:77-86.
Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:746-774.e4
Driessen A, Macken E, Moreels T, et al. Dysplasia in inflammatory bowel disease. Acta Gastroenterol Belg 2017;80:299-308.
Boltin D, Levi Z, Halpern M, et al. Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn’s disease-case report and literature review. J Crohn’s Colitis 2011;5(5):461-464.
Rufo PA. Inflammatory bowel disease and neoplasia in children. Dig Dis 2014;32(4):455-462. Bernell O, Lapidus A, Hellers G. Recurrence after colectomy in Crohn’s colitis. Dis Colon Rectum 2001;44:647-654.
Rudolph WG, Uthoff SM, McAuliffe TL, et al. Indeterminate colititis: the real story. Dis Colon Rectum 2002;45:1528-1534.
Geboes K, VanEyken P. Inflammatory bowel disease unclassifed and indeterminate colitis: the role of the pathologist. J Clin Pathol 2009;62:201-205.
Meucci G, Bortoli A, Riccioli FA, et al. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-center study in northern Italy. Eur J Gastroenterol Hepatol 1999;11:909-913.
Martland GT, Shepherd NA. Indetermine colitis: definition, diagnosis, implications, and a plea for nosological sanity. Histopathol 2007;50:83-96.
